Healthy volunteers needed to test safety of experimental drug QRL-101
NCT ID NCT07421778
First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times
Summary
This early-stage study is testing a new drug, QRL-101, in healthy adults to see if it is safe and how the body processes it. About 48 participants will receive either the drug or a placebo. The goal is to gather safety information, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANT STUDY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ICON plc.
Groningen, 9728 NZ, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.